Masahide Mori

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

Akio Osa, Takeshi Uenami, Shohei Koyama et al. · JCI Insight · 2018 · 234 citations · Full text

Pharmacy, Immunology, Oncology +17

Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo

Toru Arai, Kinya Abe, Hiroto Matsuoka et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2000 · 130 citations

Life Sciences, Immunology, Pharmacology +15

A p38 MAPK inhibitor, FR-167653, ameliorates murine bleomycin-induced pulmonary fibrosis

Hiroto Matsuoka, Toru Arai, Masahide Mori et al. · American Journal of Physiology-Lung Cellular and Molecular Physiology · 2002 · 115 citations

Life Sciences, Cell Biology, Pharmacology +16

The translation elongation factor eEF2 is a novel tumor-associated antigen overexpressed in various types of cancers

Yusuke Oji, Naoya Tatsumi, Mari Fukuda et al. · International Journal of Oncology · 2014 · 88 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cell Surface Tetraspanin CD9 Mediates Chemoresistance in Small Cell Lung Cancer

Satoshi Kohmo, Takashi Kijima, Yasushi Otani et al. · Cancer Research · 2010 · 73 citations · Full text

Medicine, Cell Biology, Oncology +17